Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis

Affiliations

• ¹ Division of Infectious Diseases, Brigham and Women's Hospital, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
• ² Institutes of Infection and Global Health and Translational Medicine, University of Liverpool, Liverpool, UK.
• ³ Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Division of Global Health Equity, Brigham and Women's Hospital, Partners In Health, Boston, MA, USA. gvelasquez@bwh.harvard.edu.